1) Basoglu A, Baspinar N,Tenori L, Licari C, Gulersoy E. Nuclear magnetic resonance (NMR)-based metabolome profile evaluation in dairy cows with and without displaced abomasum. Veterinary Quarterly 40, 1-15, 2020.
2) Basoglu A, Sen I, Meoni G, Tenori L, Naseri A. NMR based plasma metabolomics at set intervals in newborn dairy calves with severe sepsis. Mediators of Inflammation 2018; doi:10.1155/2018/8016510, 2018.
3) Basoglu A, Baspinar N, Tenori L, Hu X, Yildiz R. NMR based metabolomics evaluation in neonatal calves with acute diarrhea and suspected sepsis: a new approach for biomarker/s, Metabolomics Open acces 2, 134, 2014.
4) Bélanger M, Heather L. Sorenson HL, France MK, Bowie MV, Barbet AF, et al. Comparison of serological detection methods for diagnosis of Ehrlichia canis infections in dogs. Journal of Clinical Microbiology 40, 3506–3508, 2002.
5) Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 289–300, 1995.
6) Buzzard SL, Bissell BD, Melissa L. Bastin T. Ehrlichiosis presenting as severe sepsis and meningoencephalitis in an immunocompetent adult. JMM Case Rep. 5, e005162, 2018.
7) Chochlios TA, Angelidou E, Kritsepi- Konstantinou M, Koutinas CK, Mylonakis ME. Seroprevalence and risk factors associated with Ehrlichia canis in a hospital canine population. Vet Clin Pathol 48, 305– 309, 2019.
8) Csokai J, Klas EM, Heusinger A, Müller E. Occurrence of Ehrlichia canis in dogs living in Germany and comparison of direct and indirect diagnostic methods. Tierarztl Prax Ausg K Kleintiere Heimtiere 45, 301-307, 2017.
9) Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem 78, 4281–90, 2006.
10) Eoh H. Metabolomics: a window into the adaptive physiology of Mycobacterium tuberculosis. Tuberculosis 94, 538–543, 2014.
11) Fuchs TM, Eisenreich, W, Heesemann J, Goebel W. Metabolic adaptation of human pathogenic and related nonpathogenic bacteria to extra- and intracellular habitats. FEMS Microbiol Rev 36, 435–462, 2012.
12) Green P, Theilla M, Singer P. Lipid metabolism in critical illness. Current Opinion in Clinical Nutrition and Metabolic Care 19, 111–115, 2016.
13) Holmes E, Foxall PJ, Nicholson JK, Neild GH, Brown SM, Beddell CR, et al. Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal Biochem 220, 284–296, 1994.
14) Ihaka R and Gentleman RR. A language for data analysis and graphics. J Comput Stat Graph 5, 299–314, 1996.
15) Larrouy-Maumus G. Lipids as biomarkers of cancer and bacterial infections. Curr Med Chem 26, 1924-32, 2019.
16) Meiboom S and Gill D. Modified spin- echo method for measuring nuclear relaxation times. Rev Sci Instrum 29, 688–691, 1958.
17) Mylonakis ME, Harrus S, Breitschwerdt EB. An update on the treatment of canine monocytic ehrlichiosis (Ehrlichia canis). Vet J 246, 45-53, 2019.
18) Neuhäuser M. Wilcoxon-Mann-Whitney Test. In: International Encyclopedia of Statistical Science, Lovric M. ed. Springer, Berlin, Heidelberg, pp. 1656-1658, 2011.
19) Sainz Á, Roura X, Miró G, Estrada-Peña A, Kohn B, Harrus S, et al. Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe. Parasit Vectors 8,75, 2015.
20) Schwartz C, Katz DA, Larson M, Licciardi N, Kallick C, Timothy M, et al. The relationship between ehrlichiosis and the development of hematologic malignancies. Medical Hypotheses 121, 57–59, 2018.
21) Stringer KA, Serkova NJ, Karnovsky A, G u ir e K , Pai n e R, S tan difor d TJ. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol 300, L4–L11, 2011.
22) Vignoli A, Ghini V, Meoni G , Licari C , Takis PG , Tenori L, et al. High-throughput metabolomics by 1D NMR. Angew Chem Int Ed Engl. doi:10.1002/anie.201804736, 2019.
23) Westerhuis JA, van Velzen EJ, Hoefsloot HC, Smilde AK. Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. Metabolomics 6, 119–128, 2010.
24) Z h an g A, S u n H , Yan G , W an g P . Metabolomics for biomarker discovery: Moving to the clinic. BioMed Research International 2015, 1-6, 2015.
論文の公開元へ
